×
Including results for organovo investor relations
Search only for onvo investor relations
Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as ...
People also ask
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
(“Organovo”) (Nasdaq: ONVO) convened, on March 26, 2020, the special meeting of ... investor relations section of Organovo's website at ir.organovo.com.
Ticker ONVO. Exchange NYSE More. Industry Medical Laboratories ... Organovo Holdings, Inc., an early commercial ... 2021 Annual Report View Annual Report Download.
Organovo Holdings Unveils Corporate Presentation Online ... Organovo Holdings (ONVO) has released an update to notify the public and investors about a regulation ...
Missing: relations | Show results with:relations
In depth view into ONVO (Organovo Holdings) stock ... Organovo Holdings Inc (ONVO). 1.03 +0.02 (+1.98%) USD ... Investor Relations URL, http://ir.organovo.com ...
Intercompany Agreement, dated December 28, 2020, by and among Organovo Holdings, Inc., Organovo, Inc. and Viscient Biosciences, Inc. (incorporated by reference ...